Clinical Trial Update: Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery [Phase 3]

View source ↗

Summary

A Phase 3 prognostic trial evaluating metastasis in surgically resectable stage I–III non-small cell lung cancer. Results from the study have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-02-16